JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Vobarilizumab is a bispecific humanized monoclonal antibody which targets Interleukin-6 receptor subunit alpha & Albumin.